cytarabine has been researched along with calcitriol in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (28.13) | 18.7374 |
| 1990's | 12 (37.50) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 4 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carter, DL; Moore, DC; Studzinski, GP | 1 |
| Fuse, Y; Katayama, Y; Kitamura, H; Kugai, N; Matsuura, Y; Motoyoshi, K; Nagata, N; Ohkawa, H; Wada, S | 1 |
| Desforges, JF; Fogaren, T; Miller, KB; Slapak, CA | 1 |
| Gewirtz, DA; Grant, S; Jarvis, WD; Lin, PS; Pettit, GR; Swerdlow, PS; Traylor, RS; Turner, AJ; Wallace, HJ | 1 |
| Goldenberg, NA; Kolla, SS; Studzinski, GP; Xu, HM | 1 |
| De Laurenzi, A; De Rosa, L; Montuoro, A | 1 |
| Bhandal, AK; Carter, DL; Moore, DC; Studzinski, GP | 1 |
| Bhandal, AK; Hill, HZ; Reddy, KB; Studzinski, GP | 1 |
| Gahrton, G; Hellström, E; Ost, A; Putkonen, PO; Robèrt, KH; Soppi, E | 1 |
| Koenderman, AH; van den Eijnden, DH; Wijermans, PW | 1 |
| García Díez, I; Palomera, L; Torres, A; Velasco, F; Woessner, S | 1 |
| Bhandal, AK; Brelvi, ZS; Studzinski, GP | 1 |
| Hayashi, M; Hozumi, M; Okabe-Kado, J | 1 |
| Honma, Y; Hozumi, M; Kasukabe, T; Nishii, Y; Suda, T | 1 |
| Gabrilove, JL | 1 |
| Ishikura, H; Izumi, Y; Mochizuki, T; Okazaki, T; Sawada, H; Tashima, M; Uchino, H | 1 |
| Geller, RB; Hillyer, CD; Schultz, AB | 1 |
| Broekhoven, MG; Dräger, AM; Huijgens, PC; Jonkhoff, AR; Langenhuijsen, MM; Ossenkoppele, GJ; Schweitzer, CM; van de Loosdrecht, AA | 1 |
| Rathod, B; Song, S; Studzinski, GP; Uskokovic, MR; Wajchmann, HJ; Wang, X; Xu, H | 1 |
| Honma, Y; Kanatani, Y; Kasukabe, T; Makishima, M; Yamamoto-Yamaguchi, Y | 1 |
| Chan, FS; IP, NY; Leung, MF; Xie, P | 1 |
| Boccadoro, M; Campa, E; Campana, S; Dellacasa, C; Ferrero, D; Foli, C | 1 |
| Kim, CH | 1 |
| Hamaki, T; Harima, A; Hoshi, K; Kajiwara, K; Kodo, H; Kozai, Y; Mizusawa, M; Yamada, K | 1 |
| Patel, R; Studzinski, GP; Wang, X | 1 |
| Gocek, E; Liu, CG; Liu, X; Studzinski, GP; Wang, X | 1 |
3 review(s) available for cytarabine and calcitriol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Differentiation factors.
Topics: Acetamides; Antineoplastic Agents; Calcitriol; Cell Differentiation; Colony-Stimulating Factors; Cytarabine; Humans; Leukemia; Lymphokines; Retinoids; Tetradecanoylphorbol Acetate | 1986 |
The role of bone marrow transplantation in the treatment of myelodysplastic syndromes.
Topics: Bone Marrow Transplantation; Calcitriol; Cytarabine; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Isotretinoin; Myelodysplastic Syndromes; Prognosis; Transplantation, Homologous | 1995 |
1 trial(s) available for cytarabine and calcitriol
| Article | Year |
|---|---|
Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol.
Topics: Acute Disease; Administration, Oral; Age Factors; Aged; Aged, 80 and over; Bone Marrow; Calcitriol; Cytarabine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hydroxyurea; Infusions, Intravenous; Leukemia, Myeloid; Middle Aged | 1992 |
28 other study(ies) available for cytarabine and calcitriol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Inhibition by 1,25 dihydroxyvitamin D3 of c-myc down-regulation and DNA fragmentation in cytosine arabinoside-induced erythroid differentiation of K562 cells.
Topics: Blotting, Northern; Calcitriol; Cell Cycle; Cell Division; Cytarabine; DNA; Down-Regulation; Erythrocytes; Genes, myc; Heat-Shock Proteins; Hematopoiesis; Hemoglobins; Humans; Hydrogen-Ion Concentration; Leukemia, Erythroblastic, Acute; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myb; Proto-Oncogene Proteins c-myc; RNA, Messenger; Tumor Cells, Cultured | 1992 |
Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
Topics: Aclarubicin; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cisplatin; Creatinine; Cyclic AMP; Cytarabine; Etoposide; Glomerular Filtration Rate; Humans; Hydroxycholecalciferols; Hydroxyproline; Hypercalcemia; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Male; Osteocalcin; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Prednisolone; Procarbazine; Proteins | 1992 |
Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bryostatins; Calcitriol; Cytarabine; DNA; DNA Damage; DNA, Neoplasm; Drug Synergism; Humans; Lactones; Leukemia, Promyelocytic, Acute; Macrolides; NAD; Protein Kinase C; Thymidine; Time Factors; Tritium; Tumor Cells, Cultured | 1992 |
Resistance to 1,25-dihydroxyvitamin D3 of a deoxycytidine kinase-deficient variant of human leukemia HL60 cells.
Topics: Biological Transport; Calcitriol; Cell Differentiation; Cell Division; Cell Survival; Clone Cells; Cytarabine; Deoxycytidine Kinase; Drug Resistance; Gene Expression; Genes, myc; Genetic Variation; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Monocytes; Oligonucleotide Probes; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured | 1992 |
Therapy of 'high risk' myelodysplastic syndromes with an association of low-dose Ara-C, retinoic acid and 1,25-dihydroxyvitamin D3.
Topics: Aged; Aged, 80 and over; Calcitriol; Cytarabine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Risk Factors; Tretinoin | 1992 |
Inhibition by 1,25 dihydroxyvitamin D3 of chemically induced erythroid differentiation of K562 leukemia cells.
Topics: Animals; Calcitriol; Cell Differentiation; Cell Division; Cell Line; Cytarabine; Humans; Kinetics; Leukemia, Experimental; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Receptors, Calcitriol; Receptors, Steroid; Ribavirin; RNA, Messenger; Time Factors | 1991 |
Potentiation of 1-beta-D-arabinofuranosylcytosine cytotoxicity to HL-60 cells by 1,25-dihydroxyvitamin D3 correlates with reduced rate of maturation of DNA replication intermediates.
Topics: Arabinofuranosylcytosine Triphosphate; Calcitriol; Cell Differentiation; Cell Survival; Cytarabine; DNA Damage; DNA Replication; Drug Administration Schedule; Drug Synergism; Humans; Structure-Activity Relationship; Tumor Cells, Cultured | 1991 |
Effects of retinoic acid, 1,25-dihydroxyvitamin D3, cytosine arabinoside and alpha-interferon on bone marrow cells from patients with myelodysplastic syndromes.
Topics: Bone Marrow; Calcitriol; Cell Differentiation; Cell Division; Colony-Forming Units Assay; Cytarabine; DNA; Humans; In Vitro Techniques; Interferon Type I; Myelodysplastic Syndromes; Tretinoin | 1989 |
Treatment for myelodysplastic syndromes.
Topics: Aged; Calcitriol; Cytarabine; Drug Synergism; Drug Therapy, Combination; Hematopoietic Stem Cells; Humans; Myelodysplastic Syndromes; Retinoids | 1987 |
Changes in the expression of N-acetylglucosaminyltransferase III, IV, V associated with the differentiation of HL-60 cells.
Topics: Calcitriol; Carbohydrate Conformation; Carbohydrate Sequence; Cell Differentiation; Cell Line; Cytarabine; Dimethyl Sulfoxide; Glucosyltransferases; Humans; N-Acetylglucosaminyltransferases; Oligosaccharides; Tretinoin | 1987 |
[Megakaryoblastic leukemia (acute myelofibrosis): complete remission of a case with low-dose cytosine arabinoside].
Topics: Aged; Calcitriol; Cytarabine; Female; Humans; Leukemia, Megakaryoblastic, Acute; Primary Myelofibrosis; Remission Induction | 1988 |
Potentiation by 1-alpha,25-dihydroxyvitamin D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea.
Topics: Calcitriol; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Cytarabine; DNA, Neoplasm; Drug Synergism; Humans; Hydroxyurea; Leukemia, Myeloid, Acute | 1986 |
Inducibility of terminal differentiation in daunomycin- and cytosine arabinoside-resistant mouse myeloid leukemia M1 cells.
Topics: Animals; Calcitriol; Cell Differentiation; Cell Division; Cell Line; Cytarabine; Daunorubicin; Dexamethasone; Drug Resistance; Leukemia, Myeloid, Acute; Methylnitronitrosoguanidine; Mice; Organophosphorus Compounds; Poly I; Pyridinium Compounds | 1986 |
Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cell Differentiation; Cell Division; Cytarabine; Dactinomycin; Daunorubicin; Dexamethasone; Hydroxycholecalciferols; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice; Time Factors | 1987 |
Effect of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1 alpha,25-dihydroxyvitamin D3.
Topics: Antibiotics, Antineoplastic; Aphidicolin; Calcitriol; Cell Differentiation; Cell Division; Cell Line; Cytarabine; Diterpenes; DNA Replication; Humans; Hydroxyurea; Kinetics; Leukemia, Myeloid, Acute; Tretinoin | 1985 |
Spectrophotometric determination of clonogenic capacity of leukemic cells in a semisolid microtiter culture system.
Topics: Calcitriol; Clone Cells; Culture Media; Cytarabine; Humans; In Vitro Techniques; Spectrophotometry; Tumor Cells, Cultured | 1993 |
Loss of deoxcytidine kinase expression and tetraploidization of HL60 cells following long-term culture in 1,25-dihydroxyvitamin D3.
Topics: Autoradiography; Blotting, Northern; Calcitriol; Cell Cycle; Cell Division; Clone Cells; Culture Media; Cytarabine; Deoxycytidine Kinase; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression; HL-60 Cells; Humans; Ploidies; RNA, Messenger; Time Factors | 1996 |
Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Topics: Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; Azepines; Base Sequence; Calcitriol; Cell Differentiation; Cytarabine; Daunorubicin; Dexamethasone; DNA Primers; Enzyme Inhibitors; Gene Expression; Genes, jun; Genes, myc; Glucocorticoids; Humans; Leukemia, Monocytic, Acute; Molecular Sequence Data; Monocytes; Myosin-Light-Chain Kinase; RNA, Messenger; Time Factors; Transcription Factor AP-1; Tumor Cells, Cultured | 1996 |
Induction of TrkA expression by differentiation inducers in human myeloid leukemia KG-1 cells.
Topics: Butyrates; Calcitriol; Cell Differentiation; Cytarabine; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid; Receptor, trkA; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2000 |
Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cytarabine; Disease Progression; Female; Humans; Isotretinoin; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Thioguanine | 2004 |
Increased expression of N-acetylglucosaminyltransferase-V in human hepatoma cells by retinoic acid and 1alpha,25-dihydroxyvitamin D3.
Topics: Albumins; Calcitriol; Carcinoma, Hepatocellular; Cytarabine; Dimethyl Sulfoxide; Enzyme Activation; Humans; Liver Neoplasms; N-Acetylglucosaminyltransferases; Pyridines; Tretinoin | 2004 |
Induction of remission of relapsed acute myeloid leukemia after unrelated donor cord blood transplantation by concomitant low-dose cytarabine and calcitriol in adults.
Topics: Aclarubicin; Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cord Blood Stem Cell Transplantation; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid; Middle Aged; Recurrence; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction | 2006 |
hKSR-2, a vitamin D-regulated gene, inhibits apoptosis in arabinocytosine-treated HL60 leukemia cells.
Topics: Acetylcysteine; Adaptor Proteins, Signal Transducing; Antioxidants; Apoptosis; Cytarabine; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Necrosis; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Small Interfering; Vitamin D | 2008 |
MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Cell Differentiation; Cytarabine; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Leukemia, Myeloid; Membrane Proteins; MicroRNAs; Monocytes; Oligoribonucleotides, Antisense; Proto-Oncogene Proteins; U937 Cells; Up-Regulation; Vitamin D | 2011 |